Statement by President von der Leyen on Moderna
Statement given yesterday by President von der Leyen on Moderna.
The coronavirus pandemic has affected our lives severely. Many people are ill and have lost their jobs. And right now, many Europeans are worrying that they cannot see their families or their friends over Christmas.
While restrictive measures can slow down the spread of the virus in this very difficult situation, we all know that only a safe and effective vaccine will provide a lasting, a sustainable solution to this pandemic. Vaccination can help and is crucial to end the pandemic, that we overcome this virus. And here, I have today good news: I am happy to announce that tomorrow we will approve a new contract to secure another COVID-19 vaccine in our vaccine portfolio.
This contract allows us to buy up to 160 million doses of a vaccine produced by Moderna. According to the results of clinical trials, this vaccine could be highly effective against COVID-19. Once the vaccine is indeed proven as safe and effective, every Member State will receive it at the same time, on a pro-rata basis, at the same conditions.
With Moderna now, this is the sixth contract we have with a pharmaceutical company for our COVID-19 vaccine portfolio. We are working on yet another one. By this, we are setting up one of the most comprehensive COVID-19 vaccine portfolios in the world.
This provides Europeans access to the most promising future vaccines under development so far. Of course, all vaccines from our portfolio will be evaluated very carefully by our European Medicines Agency (EMA). They will only be authorised and placed on the market if they are safe and if they are effective. Transparency here is crucial and of utmost importance.
Securing rapidly vaccines for European citizens is one priority. But our other priority, at the same time, is to make sure that everyone has access to vaccines, everywhere in the world. It has to be an affordable and equitable distribution of the vaccines.
This is why we have raised, by pledging, EUR 16 billion since May for tests, treatments and diagnostics and vaccines against the coronavirus worldwide. And as Team Europe, we have contributed close to EUR 800 million to the COVAX Facility. The COVAX Facility is responsible through high-income countries donations – here the EUR 800 million by Team Europe – to make sure that low- and middle-income countries have access to the vaccines that are being produced now and in the future. The aim is to serve the world with these vaccines to end the pandemic.
We all know, we are all together in this.
Latest News from
EIB provides €20 million to support RDI activities and growth at Galenicum27/01/2021 09:25:00
The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in Barcelona in 2003 that aims to improve the quality and affordability of medicines.
First BlueInvest fund agreements secure €45 million for the blue economy26/01/2021 16:33:00
The European Commission is partnering with the European Investment Fund, to announce €45 million of BlueInvest fund financing into 2 funds targeting the blue economy across Europe.
Coming up in Parliament: vaccines, circular economy, migration26/01/2021 15:25:00
During a packed committee week, MEPs will talk about vaccines and sustainability as well as hold a hearing about Portugal’s priorities for the Council presidency the next six months.
Council adopts conclusions on climate and energy diplomacy26/01/2021 14:33:00
The Council yesterday adopted conclusions on ʻClimate and Energy Diplomacy – Delivering on the external dimension of the European Green Dealʼ.
European Commission launches Green Consumption Pledge, first companies commit to concrete actions towards greater sustainability26/01/2021 13:25:00
The European Commission yesterday launched its new Green Consumption Pledge, the first initiative delivered under the New Consumer Agenda.
European Parliament to commemorate 76 years since the liberation of Auschwitz26/01/2021 11:33:00
A virtual ceremony, including speeches by European Parliament President David Sassoli and guests, will be held on Wednesday 27 January.
Press statement by Commissioner Kyriakides on vaccine deliveries and on the vaccine export transparency scheme26/01/2021 10:33:00
Press statement given yesterday by Commissioner Kyriakides on vaccine deliveries and on the vaccine export transparency scheme.
Coronavirus: Commission proposes update to coordinated approach on free movement restrictions26/01/2021 09:25:00
The Commission yesterday proposed an update to the Council Recommendation of last October coordinating measures affecting free movement in the European Union.
Coronavirus: Commission proposes additional safeguards on travel from outside the EU and updated criteria for applying travel restrictions25/01/2021 15:25:00
Today the Commission is proposing additional safeguards and requirements for international travellers into the EU.